Solenic Medical Appoints Medical Device Industry Veteran Bart Bandy as Chief Executive Officer
Solenic completes enrollment of human feasibility study and looks ahead to pivotal trials for patients suffering from periprosthetic joint infections (PJI).
ADDISON, Texas, July 10, 2025 /PRNewswire/ — Solenic Medical, a leading innovator focused on revolutionizing orthopedic implant infection care, announced today the appointment of Bart Bandy as its new Chief Executive Officer. He brings more than 30 years of healthcare leadership experience, including a strong track record of driving growth and commercialization in both private and public medical technology companies. Mr. Bandy will lead Solenic Medical as the company prepares to expand its presence and accelerate the path to market of its proprietary alternating-magnetic-field (AMF) therapy addressing a significant unmet need in medical implant infection management.
